Announcements
- Certara Appoints New Chief Human Resources Officer & General Counsel
- Certara Reports First Quarter 2024 Financial Results
- Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
- Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
- Certara Reports Fourth Quarter 2023 Financial Results
- Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
- Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
- Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
- Certara Reports Third Quarter 2023 Financial Results
- Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
More ▼
Key statistics
As of last trade Certara Inc (700:BER) traded at 15.39, -14.63% below its 52-week high of 18.03, set on Mar 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.30 |
---|---|
High | 15.44 |
Low | 15.27 |
Bid | 15.13 |
Offer | 15.65 |
Previous close | 15.35 |
Average volume | 33.33 |
---|---|
Shares outstanding | 160.84m |
Free float | 119.70m |
P/E (TTM) | -- |
Market cap | 2.66bn USD |
EPS (TTM) | -0.3857 USD |
Data delayed at least 15 minutes, as of May 24 2024 17:35 BST.
More ▼